Biocodex and MRM Health Partner to Strengthen Production of CORAL®-Based Medicines
Published
The French laboratory Biocodex and the company MRM Health have announced the signing of a strategic partnership. The aim of this agreement is to strengthen the capacity to supply CORAL®-based medicines commercially in the future.
Biocodex is a French pharmaceutical group, based notably in France. This alliance aims to prepare the large-scale manufacturing and distribution of these products. For both companies, the goal is to better meet future demand and ensure a steady availability of the medicines concerned.
According to available information, this partnership concerns mainly commercial production. The two companies will work together to organise the supply, but certain important details, such as the precise timeline, the planned volumes or the amounts involved in the agreement, have not yet been made public.
This type of collaboration between a laboratory and an industrial partner is common in the pharmaceutical sector. It makes it possible to share expertise and secure production capabilities. The next steps of the project are expected to be communicated in the coming months.
Sources: Ma Clinique
More France news
- Maxime Pavageau, 29, wins France's best young wine seller title
- A New, Highly Promising Concrete
- Paris and Île-de-France: Immersive Exhibitions to Experience Art Differently
- France 3 broadcasts a documentary on the history of the Téléthon, narrated by Zazie
- ChatGPT launches business profiles with mention and click statistics
- Trail: France Outdoor Seeks to Frame Environmental Restrictions
- A Roanne company bets on knitwear made in France
- Sport: Major Win for the Brûleurs de Loups and Six Internationals Absent for FC Annecy